Grail said Galleri, its multi-cancer early detection test, failed to meet the primary endpoint of a recent trial. The stock slid 47%, to $54.20, in after-hours trading. Through market close, share ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Bipartisan legislation, supported by one local congressman, would provide Medicare coverage of multi-cancer early detection screening tests. The bill is called the Nancy Gardner Sewell Medicare ...

Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in stage III and IV cancers.

Discover how dual‑screen and tri‑screen laptops impact real‑world productivity, comparing folding displays, slide‑out screens, and multi‑screen laptop setups for modern mobile professionals.

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals with average risk for the disease reported finding ...